Pairing diagnostic innovation with improved patient experience, ColoSense aims to streamline the screening process and increase compliance Geneoscopy, Inc., a life sciences company focused on ...

Fecal specimen collection in the clinical setting is often unfeasible for large population studies, especially because cancer patients on immunotherapy often experience constipation. A method for ...

Background. In 68% of foodborne disease outbreaks, no etiologic pathogen is identified. In two-thirds of outbreaks with no identified etiology, no stool specimens are submitted for testing. Methods.

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Charlotte Schubert on Jun 3, 2021 at ...

A calprotectin stool test may help determine whether you have an inflammatory or noninflammatory bowel condition. The information it provides may also eliminate the need for more invasive tests. Share ...